BIORBYT LTD. Non-Antibody Products — page 528 of 3
Non-Antibody Products
Page 528 of 3,980
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| COX4I1 Immunizing peptide | n/a | 100 ug | orb17474 | More Info |
| COX-1/2-IN-1 | Purity 98.00%. MW: 349.61 | 5 mg, 50 mg, 100 mg | orb1688842 | More Info |
| COX-1/2-IN-2 | Purity 98.00%. MW: 396.61 | 5 mg, 50 mg, 100 mg | orb1688172 | More Info |
| COX-1/2-IN-3 | Purity 98.00%. MW: 332.22 | 50 mg, 100 mg, 5 mg | orb1689044 | More Info |
| COX-2-IN-1 | Purity 100.00%. MW: 442.84 | 1 mg, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg | orb1710641 | More Info |
| COX-2-IN-10 | Purity 98.00%. MW: 557.68 | 5 mg, 50 mg, 100 mg | orb1686097 | More Info |
| COX-2-IN-11 | Purity 98.00%. MW: 268.41 | 5 mg, 50 mg, 100 mg | orb1689566 | More Info |
| COX-2-IN-12 | Purity 98.00%. MW: 285.34 | 5 mg, 50 mg, 100 mg | orb1689459 | More Info |
| COX-2-IN-13 | Purity 98.00%. MW: 386.42 | 5 mg, 50 mg, 100 mg | orb1688322 | More Info |
| COX-2-IN-14 | Purity 98.00%. MW: 386.36 | 5 mg, 50 mg, 100 mg | orb1688325 | More Info |
| COX-2-IN-16 | Purity 98.00%. MW: 394.228 | 5 mg, 50 mg, 100 mg | orb1688216 | More Info |
| COX-2-IN-17 | Purity 98.00%. MW: 414.89 | 5 mg, 50 mg, 100 mg | orb1687896 | More Info |
| COX-2-IN-18 | Purity 98.00%. MW: 389.49 | 5 mg, 50 mg, 100 mg | orb1688278 | More Info |
| COX-2-IN-19 | Purity 98.00%. MW: 354.43 | 5 mg, 50 mg, 100 mg | orb1688773 | More Info |
| COX-2-IN-2 | Purity 98.85%. MW: 341.36 | 1 mg, 5 mg, 10 mg, 25 mg, 100 mg, 50 mg | orb1710642 | More Info |
| COX-2-IN-20 | Purity 98.00%. MW: 269.66 | 50 mg, 100 mg, 5 mg | orb1689558 | More Info |
| COX-2-IN-21 | Purity 98.00%. MW: 422.44 | 5 mg, 50 mg, 100 mg | orb1687781 | More Info |
| COX-2-IN-22 | Purity 98.00%. MW: 484.504 | 100 mg, 5 mg, 50 mg | orb1686826 | More Info |
| COX-2-IN-23 | Purity 98.00%. MW: 495.62 | 5 mg, 50 mg, 100 mg | orb1686695 | More Info |
| COX-2-IN-24 | Purity 98.00%. MW: 574.51 | 5 mg, 50 mg, 100 mg | orb1685976 | More Info |
| COX-2-IN-26 | Purity 98.00%. MW: 507.65 | 5 mg, 50 mg, 100 mg | orb1686562 | More Info |
| COX-2-IN-28 | Purity 98.00%. MW: 581.78 | 5 mg, 50 mg, 100 mg | orb1685930 | More Info |
| COX-2-IN-29 | Purity 98.00%. MW: 494.56 | 5 mg, 50 mg, 100 mg | orb1686707 | More Info |
| COX-2-IN-34 | Purity 98.08%. MW: 245.23 | 5 mg, 1 mg, 500 mg, 100 mg, 50 mg, 25 mg, 10 mg | orb1819036 | More Info |
| COX-2-IN-6 | Purity 98.00%. MW: 409.5 | 25 mg, 10 mg, 1 mg, 100 mg, 50 mg, 5 mg, 500 mg | orb1687977 | More Info |
| COX-2-IN-7 | Purity 98.00%. MW: 331.41 | 5 mg, 50 mg, 100 mg | orb1689058 | More Info |
| COX-2-IN-8 | Purity 98.00%. MW: 417.5 | 5 mg, 50 mg, 100 mg | orb1687864 | More Info |
| COX-2-IN-9 | Purity 98.00%. MW: 521.61 | 5 mg, 50 mg, 100 mg | orb1686393 | More Info |
| COX-1 Inhibitor IV (TFAP) | The COX-1 Inhibitor IV, TFAP controls the biological activity of COX-1. MW… | 1 g, 100 mg, 250 mg | orb525618 | More Info |
| COX4I1 Peptide | n/a | 0.1 mg | orb1234289 | More Info |
| COX4I1 siRNA (Human) | siRNA to inhibit COX4I1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1867326 | More Info |
| COX4I2 siRNA (Human) | siRNA to inhibit COX4I2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1854666 | More Info |
| COX4I1 siRNA (Mouse) | siRNA to inhibit COX4I1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848483 | More Info |
| COX4I2 siRNA (Mouse) | siRNA to inhibit COX4I2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1839066 | More Info |
| COX4I1 siRNA (Rat) | siRNA to inhibit COX4I1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1832753 | More Info |
| COX4I2 siRNA (Rat) | siRNA to inhibit COX4I2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1831271 | More Info |
| COX IV peptide | COX IV peptide. Purity > 85%. | 5 mg, 1 mg | orb382256 | More Info |
| COX IV peptide | n/a | 100 ug | orb15692 | More Info |
| COX/5-LO-IN-1 | Purity 98.00%. MW: 318.37 | 5 mg, 50 mg, 100 mg | orb1708279 | More Info |
| COX/5-LOX-IN-1 | Purity 98.00%. MW: 294.43 | 5 mg, 50 mg, 100 mg | orb1689397 | More Info |
| COX-2/15-LOX-IN-1 | Purity 98.00%. MW: 467.63 | 5 mg, 50 mg, 100 mg | orb1687044 | More Info |
| COX-2/5-LOX-IN-1 | Purity 98.00%. MW: 383.82 | 5 mg, 50 mg, 100 mg | orb1688362 | More Info |
| COX-2/5-LOX-IN-2 | Purity 98.00%. MW: 399.44 | 5 mg, 50 mg, 100 mg | orb1688129 | More Info |
| COX-2/5-LOX-IN-3 | Purity 98.00%. MW: 361.85 | 5 mg, 50 mg, 100 mg | orb1688685 | More Info |
| COX4NB | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb595829 | More Info |
| COX4NB (EMC8) Human Over-expression Lysate | EMC8 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug | orb1367182 | More Info |
| COX4NB (EMC8) Human Over-expression Lysate | Transient overexpression lysate of COX4 neighbor (COX4NB), transcript vari… | 100 ug | orb1346843 | More Info |
| COX-2/NO-IN-1 | Purity 98.00%. MW: 257.28 | 5 mg, 50 mg, 100 mg | orb1689617 | More Info |
| COX-1 Peptide | n/a | 0.1 mg | orb1234557 | More Info |
| COX10 peptide | The peptide is used to anti COX10 antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb319239 | More Info |
| COX15 peptide | The peptide is used to anti-COX15 antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb234740 | More Info |
| COX17 peptide | The peptide is used to block anti-COX17 antibody reactivity. Purity > 85%. | 5 mg, 1 mg | orb218315 | More Info |
| Cox2 peptide | n/a | 1 mg | orb393923 | More Info |
| COX-2 Peptide | n/a | 0.1 mg | orb1234556 | More Info |
| COX4 Peptide | n/a | 0.1 mg | orb1236275 | More Info |
| COX-2/PI3K-IN-1 | Purity 98.00%. MW: 411.93 | 5 mg, 50 mg, 100 mg | orb1687935 | More Info |
| COX-2/PI3K-IN-2 | Purity 98.00%. MW: 311.34 | 5 mg, 50 mg, 100 mg | orb1689261 | More Info |
| COXSACKIE A9 | n/a | 1 ml | orb82436 | More Info |
| Coxsackie A16 (G10 Strain) | n/a | 1 ml | orb179966 | More Info |
| COXSACKIE B1 (TUCSON), RECOMB. | n/a | 1 mg | orb179967 | More Info |
| Coxsackievirus and adenovirus receptor | Coxsackievirus and adenovirus receptor | 50 ug, 100 ug, 1 mg | orb1642420 | More Info |
| Coxsackievirus and adenovirus receptor homolog | Coxsackievirus and adenovirus receptor homolog | 50 ug, 100 ug, 1 mg | orb1642445 | More Info |
| Coxsackievirus A16 (strain G-10) VP0 Protein, His Tag | Cox A16 infection is very common in China, and the pathogenicity of Cox A1… | 50 ug, 500 ug | orb1710799 | More Info |
| Coxsackievirus B3 Genome polyProtein Protein | Recombinant Coxsackievirus B3 Genome polyProtein,partial. Purity >85% as d… | 100 ug, 20 ug, 1 mg | orb1478099 | More Info |
| COX-2/sEH-IN-1 | Purity 98.00%. MW: 501.48 | 5 mg, 50 mg, 100 mg | orb1686645 | More Info |
| COX10 siRNA (Human) | siRNA to inhibit COX10 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1867315 | More Info |
| COX11 siRNA (Human) | siRNA to inhibit COX11 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1867314 | More Info |
| COX14 siRNA (Human) | siRNA to inhibit COX14 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1854514 | More Info |
| COX15 siRNA (Human) | siRNA to inhibit COX15 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1867313 | More Info |
| COX16 siRNA (Human) | siRNA to inhibit COX16 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1858630 | More Info |
| COX17 siRNA (Human) | siRNA to inhibit COX17 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1861479 | More Info |
| COX18 siRNA (Human) | siRNA to inhibit COX18 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1851157 | More Info |
| COX19 siRNA (Human) | siRNA to inhibit COX19 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1854288 | More Info |
| COX20 siRNA (Human) | siRNA to inhibit COX20 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1853759 | More Info |
| COX10 siRNA (Mouse) | siRNA to inhibit COX10 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1841063 | More Info |
| COX11 siRNA (Mouse) | siRNA to inhibit COX11 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1841201 | More Info |
| COX14 siRNA (Mouse) | siRNA to inhibit COX14 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1842686 | More Info |
| COX15 siRNA (Mouse) | siRNA to inhibit COX15 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1836798 | More Info |
| COX16 siRNA (Mouse) | siRNA to inhibit COX16 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1842744 | More Info |
| COX17 siRNA (Mouse) | siRNA to inhibit COX17 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1848484 | More Info |
| COX18 siRNA (Mouse) | siRNA to inhibit COX18 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1836383 | More Info |
| COX19 siRNA (Mouse) | siRNA to inhibit COX19 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1841802 | More Info |
| COX20 siRNA (Mouse) | siRNA to inhibit COX20 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1842697 | More Info |
| COX14 siRNA (Rat) | siRNA to inhibit COX14 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1827141 | More Info |
| Cozymasei(NAD+) | NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled… | 200 mg, 100 mg, 50 mg, 25 mg, 10 mg | orb1224754 | More Info |
| CP 100356 | Purity 98.00%. MW: 560.65 | 5 mg, 50 mg, 100 mg | orb1738785 | More Info |
| CP 105696 | CP-105696 is a potent and selective Leukotriene B4 Receptor antagonist, wi… | 1 g, 100 mg, 250 mg | orb573184 | More Info |
| CP 115953 | Purity 98.00%. MW: 357.31 | 5 mg, 50 mg, 100 mg | orb1697729 | More Info |
| CP 117227 | Purity 98.00%. MW: 479.61 | 5 mg, 50 mg, 100 mg | orb1697728 | More Info |
| CP 132484 | Purity 98.00%. MW: 230.31 | 5 mg, 50 mg, 100 mg | orb1738824 | More Info |
| CP 135807 | Purity 98.00%. MW: 351.4 | 5 mg, 100 mg, 50 mg | orb1704603 | More Info |
| CP 154,526 | Purity 98.00%. MW: 364.53 | 5 mg, 50 mg, 100 mg | orb1700825 | More Info |
| CP 154526 | Purity 98.00%. MW: 400.99 | 5 mg, 50 mg, 100 mg | orb1704602 | More Info |
| CP 316311 | Purity 98.00%. MW: 327.46 | 5 mg, 50 mg, 100 mg | orb1707426 | More Info |
| CP 376395 | CP 376395 is a potent and selective CRF1 receptor antagonist (Ki values ar… | 10 mM * 1 mL in DMSO, 1 g, 100 mg, 250 mg | orb413212 | More Info |
| CP 376395 | CP 376395 is an effective and specific Corticotropin-releasing factor 1 (C… | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1223236 | More Info |
| CP 376395 | Purity 99.96%. MW: 326.48 | 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg, 1 mg | orb1302946 | More Info |
| CP 376395 | n/a | 5 mg, 10 mg, 50 mg, 100 mg | orb1884456 | More Info |
| CP 424174 | CP 424174 is an inhibitor of IL-1β post-translational processing with… | 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg | orb1219250 | More Info |
| CP 424174 | Purity 100.00%. MW: 452.99 | 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 mg | orb1298602 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile